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This panel will present NASA’s plans for ongoing and future research to define the 
requirements for Artificial Gravity (AG) as a countermeasure against the negative health 
effects of long-duration weightlessness. AG could mitigate the gravity-sensitive effects of 
spaceflight across a host of physiological systems. Bringing gravity to space could 
mitigate the sensorimotor and neuro-vestibular disturbances induced by G-transitions 
upon reaching a planetary body, and the cardiovascular deconditioning and 
musculoskeletal weakness induced by weightlessness. Of particular interest for AG 
during deep-space missions is mitigation of the Visual Impairment Intracranial Pressure 
(VIIP) syndrome that the majority of astronauts exhibit in space to varying degrees, and 
which presumably is associated with weightlessness-induced fluid shift from lower to 
upper body segments. AG could be very effective for reversing the fluid shift and thus 
help prevent VIIP. The first presentation by Dr. Charles will summarize some of the 
ground-based and (very little) space-based research that has been conducted on AG by 
the various space programs. Dr. Paloski will address the use of AG during deep-space 
exploration-class missions and describe the different AG scenarios such as intra-
vehicular, part-of-vehicle, or whole-vehicle centrifugations. Dr. Clement will discuss 
currently planned NASA research as well as how to coordinate future activities among 
NASA’s international partners. Dr. Barr will describe some possible future plans for 
using space- and ground-based partial-G analogs to define the relationship between 
physiological responses and G levels between 0 and 1. Finally, Dr. Stenger will 
summarize how the human cardiovascular system could benefit from intermittent short-
radius centrifugations during long-duration missions. 
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